Retour
29
56
35
56
81
37
55
51
Fourchette du Jour
98,41 €
100,95 €
Fourchette 52 Semaines
91,99 €
544,93 €
Volume
1 126 902
Moyenne 50J / 200J
122,45 €
/
258,44 €
Clôture Précédente
98,05 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Technology (620 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 11,3 | 12,6 |
| P/B | 3,5 | 3,0 |
| ROE % | 38,1 | 8,9 |
| Net Margin % | 39,9 | 5,6 |
| Rev Growth 5Y % | 42,6 | 9,2 |
| D/E | 0,1 | 0,3 |
Objectif de Cours des Analystes
Hold
230,00 €
+130.6%
Low: 100,00 €
High: 330,00 €
P/E Prévisionnel
34,0
BPA Prévisionnel
2,94 €
Croissance BPA (est.)
+0,0%
CA Est.
1,2 B
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2028 |
3,63 €
1,88 € – 5,53 €
|
1,6 B | 8 |
| FY2027 |
3,25 €
2,87 € – 3,52 €
|
1,4 B | 9 |
| FY2026 |
2,94 €
2,37 € – 3,28 €
|
1,2 B | 9 |
Points Clés
Revenue grew 42,62% annually over 5 years — strong growth
Earnings grew 367,48% over the past year
ROE of 38,14% indicates high profitability
Net margin of 39,91% shows strong profitability
Debt/Equity of 0,07 — conservative balance sheet
Generating 369,73M in free cash flow
Croissance
Revenue Growth (5Y)
42,62%
Revenue (1Y)38,71%
Earnings (1Y)367,48%
FCF Growth (3Y)62,55%
Qualité
Return on Equity
38,14%
ROIC7,06%
Net Margin39,91%
Op. Margin13,07%
Sécurité
Debt / Equity
0,07
Current Ratio2,61
Interest Coverage0,00
Valorisation
P/E Ratio
11,31
P/B Ratio3,48
EV/EBITDA27,59
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 38,71% | Revenue Growth (3Y) | 39,77% |
| Earnings Growth (1Y) | 367,48% | Earnings Growth (3Y) | 407,65% |
| Revenue Growth (5Y) | 42,62% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 1,04B | Net Income (TTM) | 414,07M |
| ROE | 38,14% | ROA | 20,78% |
| Gross Margin | 72,23% | Operating Margin | 13,07% |
| Net Margin | 39,91% | Free Cash Flow (TTM) | 369,73M |
| ROIC | 7,06% | FCF Growth (3Y) | 62,55% |
| Safety | |||
| Debt / Equity | 0,07 | Current Ratio | 2,61 |
| Interest Coverage | 0,00 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 11,31 | P/B Ratio | 3,48 |
| P/S Ratio | 4,51 | PEG Ratio | 0,06 |
| EV/EBITDA | 27,59 | Dividend Yield | 0,00% |
| Market Cap | 4,68B | Enterprise Value | 3,74B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1,04B | 748,02M | 531,11M | 369,50M | 250,77M |
| Net Income | 414,07M | 88,57M | 16,07M | -59,57M | -60,14M |
| EPS (Diluted) | 8,57 | 1,88 | 0,35 | -1,51 | -1,57 |
| Gross Profit | 749,46M | 544,38M | 389,00M | 270,06M | 181,59M |
| Operating Income | 135,57M | 62,60M | -13,26M | -65,20M | -60,01M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1,99B | 2,40B | 1,85B | 1,44B | 1,28B |
| Total Liabilities | 645,18M | 1,58B | 1,20B | 902,45M | 767,53M |
| Shareholders' Equity | 1,35B | 824,55M | 655,50M | 542,08M | 513,06M |
| Total Debt | 93,78M | 54,66M | 25,04M | 28,41M | 32,46M |
| Cash & Equivalents | 1,04B | 785,79M | 747,61M | 608,18M | 553,92M |
| Current Assets | 1,44B | 1,10B | 897,80M | 697,18M | 619,27M |
| Current Liabilities | 551,15M | 422,23M | 277,36M | 181,77M | 119,13M |
Scores de Stratégies
This stock passed the criteria for 8 strategies
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#843 of 1024
Custom
Capital Light Compounder
#33 of 213
#275 of 658
Growth + Value
Growth at a Reasonable Price (Peter Lynch)
#125 of 326
#29 of 154
Custom
Full Throttle
#91 of 146
#21 of 195
Custom
Lower Risk
#41 of 136
Activité Récente
Entré
Cash Flow Compounder
Mar 24, 2026
Entré
Capital Light Compounder
Mar 24, 2026
Entré
Contrarian Investing (David Dreman)
Mar 24, 2026
Entré
Growth Investing (Philip Fisher)
Mar 24, 2026
Entré
Growth at a Reasonable Price (Peter Lynch)
Mar 24, 2026
Entré
Value Investing (Warren Buffett)
Mar 24, 2026
Entré
Full Throttle
Mar 24, 2026
Entré
Lower Risk
Mar 24, 2026